Encouraging formulation and assessment of mizolastine-loaded nanosponges for management of atopic dermatitis in animal model

Key Points

• Improved treatment for atopic dermatitis observed, enhancing symptom management.
• Increased efficacy with mizolastine-loaded nanosponges, showing notable results in animal models.
• Formulation assessed through various parameters, demonstrating superior drug delivery capabilities.
• Findings support the potential for innovative therapies in dermatological conditions using nanosystems.